Cargando…

New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment

Lung cancer is caused by a malignant tumor that shows the fastest growth in both incidence and mortality and is also the greatest threat to human health and life. At present, both in terms of incidence and mortality, lung cancer is the first in male malignant tumors, and the second in female maligna...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Piao, Liang, Bin, Zhang, Zhen, Fan, Bing, Zeng, Lin, Zhou, Zhiyong, Mao, Zhifang, Xu, Quan, Yao, Weirong, Shen, Qinglin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society of Chemistry 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300523/
https://www.ncbi.nlm.nih.gov/pubmed/37388143
http://dx.doi.org/10.1039/d3ra03099g
_version_ 1785064605524951040
author Jiang, Piao
Liang, Bin
Zhang, Zhen
Fan, Bing
Zeng, Lin
Zhou, Zhiyong
Mao, Zhifang
Xu, Quan
Yao, Weirong
Shen, Qinglin
author_facet Jiang, Piao
Liang, Bin
Zhang, Zhen
Fan, Bing
Zeng, Lin
Zhou, Zhiyong
Mao, Zhifang
Xu, Quan
Yao, Weirong
Shen, Qinglin
author_sort Jiang, Piao
collection PubMed
description Lung cancer is caused by a malignant tumor that shows the fastest growth in both incidence and mortality and is also the greatest threat to human health and life. At present, both in terms of incidence and mortality, lung cancer is the first in male malignant tumors, and the second in female malignant tumors. In the past two decades, research and development of antitumor drugs worldwide have been booming, and a large number of innovative drugs have entered clinical trials and practice. In the era of precision medicine, the concept and strategy of cancer from diagnosis to treatment are experiencing unprecedented changes. The ability of tumor diagnosis and treatment has rapidly improved, the discovery rate and cure rate of early tumors have greatly improved, and the overall survival of patients has benefited significantly, with a tendency to transform to a chronic disease with tumor. The emergence of nanotechnology brings new horizons for tumor diagnosis and treatment. Nanomaterials with good biocompatibility have played an important role in tumor imaging, diagnosis, drug delivery, controlled drug release, etc. This article mainly reviews the advancements in lipid-based nanosystems, polymer-based nanosystems, and inorganic nanosystems in the diagnosis and treatment of non-small-cell lung cancer (NSCLC).
format Online
Article
Text
id pubmed-10300523
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher The Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-103005232023-06-29 New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment Jiang, Piao Liang, Bin Zhang, Zhen Fan, Bing Zeng, Lin Zhou, Zhiyong Mao, Zhifang Xu, Quan Yao, Weirong Shen, Qinglin RSC Adv Chemistry Lung cancer is caused by a malignant tumor that shows the fastest growth in both incidence and mortality and is also the greatest threat to human health and life. At present, both in terms of incidence and mortality, lung cancer is the first in male malignant tumors, and the second in female malignant tumors. In the past two decades, research and development of antitumor drugs worldwide have been booming, and a large number of innovative drugs have entered clinical trials and practice. In the era of precision medicine, the concept and strategy of cancer from diagnosis to treatment are experiencing unprecedented changes. The ability of tumor diagnosis and treatment has rapidly improved, the discovery rate and cure rate of early tumors have greatly improved, and the overall survival of patients has benefited significantly, with a tendency to transform to a chronic disease with tumor. The emergence of nanotechnology brings new horizons for tumor diagnosis and treatment. Nanomaterials with good biocompatibility have played an important role in tumor imaging, diagnosis, drug delivery, controlled drug release, etc. This article mainly reviews the advancements in lipid-based nanosystems, polymer-based nanosystems, and inorganic nanosystems in the diagnosis and treatment of non-small-cell lung cancer (NSCLC). The Royal Society of Chemistry 2023-06-28 /pmc/articles/PMC10300523/ /pubmed/37388143 http://dx.doi.org/10.1039/d3ra03099g Text en This journal is © The Royal Society of Chemistry https://creativecommons.org/licenses/by-nc/3.0/
spellingShingle Chemistry
Jiang, Piao
Liang, Bin
Zhang, Zhen
Fan, Bing
Zeng, Lin
Zhou, Zhiyong
Mao, Zhifang
Xu, Quan
Yao, Weirong
Shen, Qinglin
New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment
title New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment
title_full New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment
title_fullStr New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment
title_full_unstemmed New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment
title_short New insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment
title_sort new insights into nanosystems for non-small-cell lung cancer: diagnosis and treatment
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10300523/
https://www.ncbi.nlm.nih.gov/pubmed/37388143
http://dx.doi.org/10.1039/d3ra03099g
work_keys_str_mv AT jiangpiao newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment
AT liangbin newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment
AT zhangzhen newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment
AT fanbing newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment
AT zenglin newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment
AT zhouzhiyong newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment
AT maozhifang newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment
AT xuquan newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment
AT yaoweirong newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment
AT shenqinglin newinsightsintonanosystemsfornonsmallcelllungcancerdiagnosisandtreatment